Valiant Laboratories Limited (NSE:VALIANTLAB)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Manufacturing of Chemicals Business	2.37B	1.33B	1.82B	3.34B	3.12B
Manufacturing of Chemicals Business Growth	78.04%	-26.74%	-45.48%	6.90%	-
Total	2.37B	1.33B	1.82B	3.34B	3.12B
Total Growth	78.04%	-26.74%	-45.48%	6.90%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India	1.33B	1.81B	3.33B	3.10B
India Growth	-26.71%	-45.55%	7.19%	-
outside India	6.41M	9.37M	13.04M	20.65M
outside India Growth	-31.59%	-28.09%	-36.87%	-
Total	1.33B	1.82B	3.34B	3.12B
Total Growth	-26.74%	-45.48%	6.90%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error